130 related articles for article (PubMed ID: 31799839)
21. Identification of a meander region proline residue critical for heme binding to cytochrome P450: implications for the catalytic function of human CYP4B1.
Zheng YM; Fisher MB; Yokotani N; Fujii-Kuriyama Y; Rettie AE
Biochemistry; 1998 Sep; 37(37):12847-51. PubMed ID: 9737862
[TBL] [Abstract][Full Text] [Related]
22. Characterization of an Additional Splice Acceptor Site Introduced into CYP4B1 in Hominoidae during Evolution.
Schmidt EM; Wiek C; Parkinson OT; Roellecke K; Freund M; Gombert M; Lottmann N; Steward CA; Kramm CM; Yarov-Yarovoy V; Rettie AE; Hanenberg H
PLoS One; 2015; 10(9):e0137110. PubMed ID: 26355749
[TBL] [Abstract][Full Text] [Related]
23. ω-
Scott EE
J Biol Chem; 2017 Mar; 292(13):5622-5623. PubMed ID: 28363936
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and evaluation of a 18F-labeled 4-ipomeanol as an imaging agent for CYP4B1 gene prodrug activation therapy.
Moon BS; Jang SJ; Kim SJ; Lee TS; Chi DY; Lee BC; Kang JH; Kim SE
Cancer Biother Radiopharm; 2013 Oct; 28(8):588-97. PubMed ID: 23682585
[TBL] [Abstract][Full Text] [Related]
25. Active site characteristics of CYP4B1 probed with aromatic ligands.
Henne KR; Fisher MB; Iyer KR; Lang DH; Trager WF; Rettie AE
Biochemistry; 2001 Jul; 40(29):8597-605. PubMed ID: 11456500
[TBL] [Abstract][Full Text] [Related]
26. A chimeric fusion protein of cytochrome CYP4B1 and green fluorescent protein for detection of pro-drug activating gene delivery and for gene therapy in malignant glioma.
Rainov NG; Sena-Esteves M; Fraefel C; Dobberstein KU; Chiocca EA; Breakefield XO
Adv Exp Med Biol; 1998; 451():393-403. PubMed ID: 10026902
[TBL] [Abstract][Full Text] [Related]
27. Noncovalent interactions dominate dynamic heme distortion in cytochrome P450 4B1.
Jennings GK; Hsu MH; Shock LS; Johnson EF; Hackett JC
J Biol Chem; 2018 Jul; 293(29):11433-11446. PubMed ID: 29858244
[TBL] [Abstract][Full Text] [Related]
28. CYP4B1 activates 4-ipomeanol in rat lung.
Verschoyle RD; Philpot RM; Wolf CR; Dinsdale D
Toxicol Appl Pharmacol; 1993 Dec; 123(2):193-8. PubMed ID: 8248926
[TBL] [Abstract][Full Text] [Related]
29. Optimized human CYP4B1 in combination with the alkylator prodrug 4-ipomeanol serves as a novel suicide gene system for adoptive T-cell therapies.
Roellecke K; Virts EL; Einholz R; Edson KZ; Altvater B; Rossig C; von Laer D; Scheckenbach K; Wagenmann M; Reinhardt D; Kramm CM; Rettie AE; Wiek C; Hanenberg H
Gene Ther; 2016 Jul; 23(7):615-26. PubMed ID: 27092941
[TBL] [Abstract][Full Text] [Related]
30. Mutagenic activation of 3-methoxy-4-aminoazobenzene by mouse renal cytochrome P450 CYP4B1: cloning and characterization of mouse CYP4B1.
Imaoka S; Hiroi T; Tamura Y; Yamazaki H; Shimada T; Komori M; Degawa M; Funae Y
Arch Biochem Biophys; 1995 Aug; 321(1):255-62. PubMed ID: 7639529
[TBL] [Abstract][Full Text] [Related]
31. Species Differences in Microsomal Oxidation and Glucuronidation of 4-Ipomeanol: Relationship to Target Organ Toxicity.
Parkinson OT; Teitelbaum AM; Whittington D; Kelly EJ; Rettie AE
Drug Metab Dispos; 2016 Oct; 44(10):1598-602. PubMed ID: 27468999
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of VEGF expression and corneal neovascularization by siRNA targeting cytochrome P450 4B1.
Seta F; Patil K; Bellner L; Mezentsev A; Kemp R; Dunn MW; Schwartzman ML
Prostaglandins Other Lipid Mediat; 2007 Nov; 84(3-4):116-27. PubMed ID: 17991614
[TBL] [Abstract][Full Text] [Related]
33. A transgenic mouse expressing human CYP4B1 in the liver.
Imaoka S; Hayashi K; Hiroi T; Yabusaki Y; Kamataki T; Funae Y
Biochem Biophys Res Commun; 2001 Jun; 284(3):757-62. PubMed ID: 11396967
[TBL] [Abstract][Full Text] [Related]
34. Bioactivation of phencyclidine in rat and human liver microsomes and recombinant P450 2B enzymes: evidence for the formation of a novel quinone methide intermediate.
Driscoll JP; Kornecki K; Wolkowski JP; Chupak L; Kalgutkar AS; O'Donnell JP
Chem Res Toxicol; 2007 Oct; 20(10):1488-97. PubMed ID: 17892269
[TBL] [Abstract][Full Text] [Related]
35. Use of Phenoxyaniline Analogues To Generate Biochemical Insights into the Interactio n of Polybrominated Diphenyl Ether with CYP2B Enzymes.
Chen C; Liu J; Halpert JR; Wilderman PR
Biochemistry; 2018 Feb; 57(5):817-826. PubMed ID: 29215266
[TBL] [Abstract][Full Text] [Related]
36. Metabolism of Benzalkonium Chlorides by Human Hepatic Cytochromes P450.
Seguin RP; Herron JM; Lopez VA; Dempsey JL; Xu L
Chem Res Toxicol; 2019 Dec; 32(12):2466-2478. PubMed ID: 31730751
[TBL] [Abstract][Full Text] [Related]
37. Bioactivation of 4-Ipomeanol by a CYP4B enzyme in bovine lung and inhibition by HET0016.
Parkinson OT; Kelly EJ; Bezabih E; Whittington D; Rettie AE
J Vet Pharmacol Ther; 2012 Aug; 35(4):402-5. PubMed ID: 21919916
[No Abstract] [Full Text] [Related]
38. Suppression of cytochrome P450 4B1: An early event in adrenocortical tumorigenesis.
Murtha TD; Korah R; Carling T
Surgery; 2017 Jan; 161(1):257-263. PubMed ID: 27865598
[TBL] [Abstract][Full Text] [Related]
39. Promoter activity and regulation of the corneal CYP4B1 gene by hypoxia.
Mastyugin V; Mezentsev A; Zhang WX; Ashkar S; Dunn MW; Laniado-Schwartzman M
J Cell Biochem; 2004 Apr; 91(6):1218-38. PubMed ID: 15048876
[TBL] [Abstract][Full Text] [Related]
40. Inhibitory effect of dietary 4-ipomeanol on DNA adduct formation by the food mutagen 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in male CDF1 mice.
Cummings DA; Schut HA
Carcinogenesis; 1995 Oct; 16(10):2523-9. PubMed ID: 7586161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]